Marquette Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Marquette Asset Management's NVS Position: Q2 2026 in Review
Marquette Asset Management sold out of Novartis (NVS) in Q2 2026, closing a stake of 17 shares — an estimated $2.6K sold.
Marquette Asset Management first reported a position in NVS in Q1 2020 and held it in 25 quarters. The position peaked at $47K in Q2 2020. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Marquette Asset Management reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Marquette Asset Management sold 17 Novartis shares in Q2 2026, an estimated $2.6K.
- Marquette Asset Management first reported a position in Novartis in Q1 2020 and held it in 25 quarters.
- Marquette Asset Management's Novartis position peaked at $47K in Q2 2020.
- 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.